List of Excipients in API macimorelin acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing macimorelin acetate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novo Nordisk | MACRILEN | macimorelin acetate | 0169-1401 | CROSPOVIDONE | 2024-12-20 |
Novo Nordisk | MACRILEN | macimorelin acetate | 0169-1401 | LACTOSE MONOHYDRATE | 2024-12-20 |
Novo Nordisk | MACRILEN | macimorelin acetate | 0169-1401 | SACCHARIN SODIUM | 2024-12-20 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for macimorelin acetate
Excipient focus: CROSPOVIDONE
macimorelin acetate drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Novo Nordisk | macimorelin acetate | 0169-1401 |
Strongbridge US Inc | macimorelin acetate | 71090-002 |
>Company | >Ingredient | >NDC |
macimorelin acetate drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
macimorelin acetate drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Novo Nordisk | macimorelin acetate | 0169-1401 |
Strongbridge US Inc | macimorelin acetate | 71090-002 |
>Company | >Ingredient | >NDC |
macimorelin acetate drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
macimorelin acetate drug variants containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Novo Nordisk | macimorelin acetate | 0169-1401 |
Strongbridge US Inc | macimorelin acetate | 71090-002 |
>Company | >Ingredient | >NDC |
macimorelin acetate drug variants not containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
macimorelin acetate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novo Nordisk | macimorelin acetate | 0169-1401 |
Strongbridge US Inc | macimorelin acetate | 71090-002 |
>Company | >Ingredient | >NDC |
macimorelin acetate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
macimorelin acetate drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Novo Nordisk | macimorelin acetate | 0169-1401 |
Strongbridge US Inc | macimorelin acetate | 71090-002 |
>Company | >Ingredient | >NDC |
macimorelin acetate drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.